Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 5;7(12):002029.
doi: 10.12890/2020_002029. eCollection 2020.

Cutaneous Manifestations in Four Patients with COVID-19

Ana Gorgulho  1 , Maria Margarida Andrade  1 , Ana Paula Antunes  1 , Inês Nabais  1 , Filipa Taborda  1 , Marta Dias Ramos  1 , Ana Maria Grilo  1
Affiliations

Cutaneous Manifestations in Four Patients with COVID-19

Ana Gorgulho et al. Eur J Case Rep Intern Med. .

Abstract

As the numbers of SARS-CoV-2 infections increased globally, reports of cutaneous manifestations started to emerge. We describe several patients with COVID-19 who presented with skin changes. We noted such manifestations in four out of 110 patients (3.63%) and describe the clinical situation of each of these patients. Each patient had either a maculopapular or a urticariform rash. These manifestations have a broad differential diagnosis and it was difficult to exclude drug reactions. We hope to raise awareness of this possible manifestation of COVID-19 in order to raise suspicion of this diagnosis among clinicians when they encounter patients with fever and rash. Larger series that also include patients with mild disease and skin biopsies may be useful.

Learning points: Cutaneous manifestations can occur as part of COVID-19, so clinicians should be suspicious of this diagnosis in patients with fever and rash.The differential diagnosis is large and drug reactions are difficult to rule out.

Keywords: COVID-19; SARS-CoV-2; dermatology; rash; skin.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interests: The Authors declare that there are no competing interests.

Figures

Figure 1
Figure 1
Pruritic maculopapular rash on the torso
Figure 2
Figure 2
Morbilliform rash on the back
Figure 3
Figure 3
Urticariform rash on the thigh
Figure 4
Figure 4
Urticariform rash on the arm
Figure 5
Figure 5
Erythematous papular rash on the torso
See this image and copyright information in PMC

References

    1. Galván Casas C, Catala A, Carretero Hernandez G, Rodriguez-Jimenez P, Fernandez-Nieto D, Rodriguez-Villa Lario A, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71–77. - PMC - PubMed
    1. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020;34(5):e212–e213. - PubMed
    1. Matar S, Oules B, Sohier P, Chosidow O, Beylot-Barry M, Dupin N, et al. Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature. J Eur Acad Dermatol Venereol. Jun 26; doi: 10.1111/jdv.16775. Online ahead of print. - DOI - PMC - PubMed

LinkOut - more resources